Chandra Bhagat Pharma (BOM:542934) LT-Debt-to-Total-Asset: 0.03 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:542934 Chandra Bhagat Pharma Ltd BOM:542934
65 GF Score
Price ₹37.92
GF Value ₹70.17
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Chandra Bhagat Pharma LT-Debt-to-Total-Asset?

Chandra Bhagat Pharma BOM:542934 +4.98% 65 LT-Debt-to-Total-Asset is 0.03 as of Mar. 2026. GuruFocus rates BOM:542934 with a GF Score™ of 65/100 and a GF Value™ of ₹70.17 (Possible Value Trap). The stock has 4 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Chandra Bhagat Pharma's long-term debt to total assests ratio for the quarter that ended in Mar. 2026 was 0.03.

Chandra Bhagat Pharma's long-term debt to total assets ratio increased from Mar. 2025 (0.02) to Mar. 2026 (0.03). It may suggest that Chandra Bhagat Pharma is progressively becoming more dependent on debt to grow their business.

Chandra Bhagat Pharma  (BOM:542934) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Chandra Bhagat Pharma LT-Debt-to-Total-Asset Related Terms

Chandra Bhagat Pharma LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Chandra Bhagat Pharma's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chandra Bhagat Pharma LT-Debt-to-Total-Asset Chart

Chandra Bhagat Pharma Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.08 0.07 0.01 0.02 0.03

Chandra Bhagat Pharma Semi-Annual Data
Mar17 Mar18 Mar19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 0.02 0.01 0.03
BOM:542934
65GF Score
Chandra Bhagat Pharma Ltd BOM:542934
LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chandra Bhagat Pharma LT-Debt-to-Total-Asset Calculation

Chandra Bhagat Pharma's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (A: Mar. 2026 )=Long-Term Debt & Capital Lease Obligation (A: Mar. 2026 )/Total Assets (A: Mar. 2026 )
=25.681/942.058
=0.03

Chandra Bhagat Pharma's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (Q: Mar. 2026 )=Long-Term Debt & Capital Lease Obligation (Q: Mar. 2026 )/Total Assets (Q: Mar. 2026 )
=25.681/942.058
=0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.03 mean?
Chandra Bhagat Pharma (BOM:542934) has a LT-Debt-to-Total-Asset of 0.03 as of Mar. 2026. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Chandra Bhagat Pharma and its competitors.
Is Chandra Bhagat Pharma's LT-Debt-to-Total-Asset too high?
Chandra Bhagat Pharma's current LT-Debt-to-Total-Asset is 0.03. Overall, Chandra Bhagat Pharma has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Chandra Bhagat Pharma's LT-Debt-to-Total-Asset compare to MCK and COR?
Chandra Bhagat Pharma's LT-Debt-to-Total-Asset of 0.03 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Medical Distribution company?
A good LT-Debt-to-Total-Asset depends on the Medical Distribution industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Chandra Bhagat Pharma and its competitors. Chandra Bhagat Pharma's current LT-Debt-to-Total-Asset is 0.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chandra Bhagat Pharma stock overvalued right now?
Based on GuruFocus' analysis, Chandra Bhagat Pharma (BOM:542934) is currently considered Possible Value Trap. The stock's GF Value™ is ₹70.17, compared to a current price of ₹37.92 — trading 46% below its estimated fair value. The current LT-Debt-to-Total-Asset is 0.03. Chandra Bhagat Pharma's overall GF Score™ is 65/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Chandra Bhagat Pharma (BOM:542934), the current LT-Debt-to-Total-Asset is 0.03 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Chandra Bhagat Pharma (BOM:542934) Overvalued in 2026?

Based on GuruFocus' analysis, Chandra Bhagat Pharma stock appears to be undervalued. The current stock price of ₹37.92 is trading 46% below its estimated GF Value™ of ₹70.17. GuruFocus considers Chandra Bhagat Pharma to be Possible Value Trap.

Key valuation signals for BOM:542934:

  • LT-Debt-to-Total-Asset: 0.03
  • GF Value™: ₹70.17 vs. price of ₹37.92 (46% below fair value)
  • GF Score™: 65/100 with 4 warning signs

No single metric tells the full story. See the BOM:542934 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Chandra Bhagat Pharma Business Description

Address Doctor Ambedkar Road, 323-F, Flat 1,2, Bhagat Bhuvan, Matunga East, Mumbai, MH, IND, 400019
Chandra Bhagat Pharma Ltd is a pharmaceutical company marketing pharmaceutical, critical care, and health care products across the globe. The company deals in many categories of pharmaceutical products like anticancer, cardiovascular, anti-infective, etc. It offers various forms of pharmaceutical products, like oral solids. tablets, capsules, liquid orals, syrup suspension, injections, liquid, powder, etc. Additionally, the company is also engaged in promoting and marketing of Active Pharmaceutical Ingredients (API's) in India.
65GF Score

Get the complete analysis for BOM:542934

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹37.92
Price
₹70.17
GF Value